TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
1.740
+0.130 (8.07%)
At close: Dec 5, 2025, 4:00 PM EST
1.630
-0.110 (-6.32%)
After-hours: Dec 5, 2025, 5:42 PM EST
TherapeuticsMD Market Cap
TherapeuticsMD has a market cap or net worth of $20.14 million as of December 5, 2025. Its market cap has increased by 34.26% in one year.
Market Cap
20.14M
Enterprise Value
19.51M
1-Year Change
34.26%
Ranking
Category
Stock Price
$1.74
Market Cap Chart
Since April 23, 2013, TherapeuticsMD's market cap has decreased from $204.60M to $20.14M, a decrease of -90.16%. That is a compound annual growth rate of -16.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 20.10M | 103.03% |
| Dec 31, 2024 | 9.90M | -58.40% |
| Dec 29, 2023 | 23.80M | -55.01% |
| Dec 30, 2022 | 52.90M | -64.99% |
| Dec 31, 2021 | 151.10M | -54.23% |
| Dec 31, 2020 | 330.10M | -49.70% |
| Dec 31, 2019 | 656.20M | -27.60% |
| Dec 31, 2018 | 906.30M | -30.67% |
| Dec 29, 2017 | 1.31B | 15.24% |
| Dec 30, 2016 | 1.13B | -38.50% |
| Dec 31, 2015 | 1.84B | 165.63% |
| Dec 31, 2014 | 694.30M | -8.08% |
| Dec 31, 2013 | 755.30M | 269.16% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |